Acoramidis Slowed the Decline in Daily Function for Amyloid Heart Disease Patients, a New Trial Analysis Finds
A JAMA Cardiology analysis found acoramidis slowed decline in daily function for ATTR-CM patients. Here is what the 30-month data show.
Medical Daily ·